angiotensin ii has been researched along with imperatorin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Duan, H; He, L; Zhan, Y; Zhang, Y | 1 |
| He, H; He, J; He, L; Song, J; Wang, T; Zhou, N | 1 |
| He, H; He, J; He, L; Wang, T; Zhang, Y; Zhou, N | 1 |
| Shi, X; Wang, J; Yong, S; Zhang, P; Zhou, N | 1 |
4 other study(ies) available for angiotensin ii and imperatorin
| Article | Year |
|---|---|
Furanocoumarins-imperatorin inhibits myocardial hypertrophy both in vitro and in vivo.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular Agents; Cells, Cultured; Furocoumarins; Heart Failure; Molecular Structure; Myocardium; Myocytes, Cardiac; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley | 2010 |
Antihypertensive and vascular remodelling effects of the imperatorin derivative OW1 in renovascular hypertension rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Blood Urea Nitrogen; Calcitonin Gene-Related Peptide; Collagen Type I; Collagen Type III; Disease Models, Animal; Furocoumarins; Hypertension, Renovascular; Kidney; Male; Mesenteric Arteries; Random Allocation; Rats; Rats, Sprague-Dawley; Renal Artery; Vascular Remodeling; Vasodilator Agents | 2014 |
The imperatorin derivative OW1, a new vasoactive compound, inhibits VSMC proliferation and extracellular matrix hyperplasia.
Topics: Actins; Angiotensin II; Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Pressure; Calcium Channels; Cell Proliferation; Collagen Type I; Collagen Type III; Extracellular Matrix; Furocoumarins; Hyperplasia; Hypertension, Renovascular; Male; Matrix Metalloproteinases; Mesenteric Arteries; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats; Rats, Sprague-Dawley | 2015 |
Imperatorin derivative OW1, a new vasoactive compound, attenuates cell proliferation and migration by inhibiting Nox1-mediated oxidative stress.
Topics: Angiotensin II; Animals; Cell Movement; Cell Proliferation; Cells, Cultured; Mice; Myocytes, Smooth Muscle; NADPH Oxidase 1; NIH 3T3 Cells; Oxidative Stress; Rats; Reactive Oxygen Species; Vascular Remodeling | 2023 |